Latest filing published 18 Mar 2021 for T2 Biosystems, Inc., €15k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -7.1%Entry US$27.49 · Close at T+365 US$25.52
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Anthony Pare: trading record in brief
This profile gathers the share dealings of Anthony Pare across 2 companies, led by Haemonetics Corp and T2 Biosystems, Inc. The record holds 7 filings, for trades running from 21 April 2008 to 17 March 2021.
In open-market terms, that means 1 purchase worth €6,638 on one side and 3 sales worth €51k on the other. Sales outweigh purchases by €44k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 3 option exercises. 2021 to date brings no purchases and 1 sale.
The latest filing, published on 18 March 2021, reports an open-market sale of €15k in T2 Biosystems, Inc. The most recent open-market purchase was published on 5 May 2008, 6,762 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Anthony Pare
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,620 shares@ US$1.84100.0% of flowCommon StockSEC:0000899243-21-012547:0
- 17,500 sharesCommon StockSEC:0000899243-21-011891:0
- 500 shares@ US$26.11Common StockSEC:0000313143-08-000038:0
- 500 shares@ US$57.40Common StockSEC:0000313143-08-000038:1
- 231 shares@ US$44.35Common StockSEC:0000313143-08-000016:0Canonical exit: 30 Jul 2008 (T+90)
- 500 shares@ US$26.11Common StockSEC:0000313143-08-000014:0
- 500 shares@ US$55.98Common StockSEC:0000313143-08-000014:1
7 of 7 declarations
